The origins, patterns and implications of human spontaneous mutation

Nature Reviews Genetics

Volumn 1, Issue 1, 2000, Pages 40-47

  Crow, James F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; GENETIC SELECTION; HUMAN; MALE; MUTATION; PATERNAL AGE; REVIEW;

FEMALE; GERM-LINE MUTATION; HUMANS; MALE; PATERNAL AGE; SELECTION (GENETICS);

EID: 0034303523     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/35049558     Document Type: Review

References (56)

1. Weinberg, W. Zur Vererbung des Zwergwuchses. Arch. Rassen-u. Gesel. Biolog. 9, 710-718 (1912). In this paper, Weinberg first noted the importance of birth order, which led to the idea of the paternal age effect.
2. Crow, J. F. Hardy, Weinberg and language impediments. Genetics 152, 821-825 (1999).
3. Penrose, L. S. Parental age and mutation. Lancet 269, 312-313 (1955).
4. Risch, N., Reigh, E. W., Wishnick, M. W. & McCarthy, J. G. Spontaneous mutation and parental age in humans. Am. J. Hum. Genet. 41, 218-248 (1987). A detailed review and analysis of the classical literature on the paternal age effect.
5. Haldane, J. B. S. The mutation rate of the gene for hemophilia and its segregation ratios in males and females. Ann. Eugen. 13, 262-271 (1947). The first measurement of a human mutation rate, as well as evidence for a higher male rate.
6. Becker, J. et al. Characterizatbn of the factor VIII defect in 147 patients with sporadic hemophila A: Family studies indicate a mutation type-dependent sex ratio of mutation frequencies. Am. J. Hum. Genet. 58, 657-670 (1996). The different kinds of mutation events leading to haemophilia and their relative frequency.
7. Ketterling, R. P. et al. Germline origins in the human F9 gene: frequent G:C → A:T mosaicism and increased mutations with advanced maternal age. Hum. Genet. 105, 629-640 (1999).
8. Green, P. M. et al. Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B. Am. J. Hum. Genet. 65, 1572-1579 (1999).
9. Francke, U. et al. The occurrence of new mutants in the X-linked recessive Lesch-Nyhan disease. Am. J. Hum. Genet. 28, 123-137 (1976).
10. Tuchman, M. et al. Reportions of spontaneous mutations in males and females with omithine transcarbamylase deficiency. Am. J. Med. Genet. 55, 67-70 (1995).
11. Thomas, G. H. High male:female ratio of germ-line mutations: An alternative explanation for postulated gestational lethality in mates in X-linked dominant disorders. Am. J. Hum. Genet. 58, 1364-1368 (1996).
12. Wilkin, D. J. et al. Mutations in fibrolast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am. J. Hum. Genet. 63, 711-716 (1998). A demonstration that achondroplasia mutations all occur in the father and at a particular CpG hot-spot.
13. Moloney, D. M. et al. Exclusive paternal origin of new mutations in Apert syndrome. Nature Genet. 13, 48-53 (1996).
14. Carlson, K. M. et al. Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am. J. Hum. Genet. 55, 1076-1082 (1994).
15. Schuffenecker, I. et al. Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Am. J. Hum. Genet. 60, 233-237 (1997).
16. Glaser, R. L. et al. Paternal origin of FGFR2 mutations in sporadic cases of Crouzon Syndrome and Pfeiffer Syndrome. Am. J. Hum. Genet. 66, 768-777 (2000).
17. Bellus, G. A. et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am. J. Hum. Genet. 56, 368-373 (1995).
18. Vajo, Z, Francomano, C. A. & Wilkin, D. J. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dyplasias. Muenke cranosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr. Rev. 21, 23-39 (2000). This paper summarizes the molecular events at the three loci with the highest male:female mutation rate ratio.
19. Kitamura, Y. et al. Maternally derived missense mutations in the tyrosine kinase domain of the ret protooncogene in a patient with de-novo men-2b. Hum. Mol. Genet. 4, 1987-1988 (1995).
20. Vogel, F. & Rathenberg, R. Spontaneous mutation in man. Adv. Hum. Genet. 5, 223-318 (1975).
21. Drost, J. B. & Lee, W. R. Biological basis of germline mutation: Comparisons of spontaneous germline mutation rates among Drosophila, mouse, and human. Env. Mol. Mut. 25 (S26), 48-64 (1995).
22. Vogel, F. & Motulsky, A. G. Human Genetics; Problems and Approaches. (Springer, Berlin, 1997). An unusually complete textbook of human genetics, with detail on mutation.
23. Grimm, T. G. et al. On the origin of deletetions and print mutations in Duchenne muscular dystrophy: most deletions arise in oogenesis and most point mutations result from events in spermatogenesis. J. Med. Gen. 31, 183-186 (1994).
24. Lazaro, C. et al. Sex differences in the mutation rate and mutational mechanism in the NF gene in neurofibromatosis type 1 patients. Hum. Genet. 98, 696-699 (1996).
25. Fahsold, R. et al. Minor lesion mutational spectrum of the entire NF1 gone does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am. J. Hum. Genet. 66, 790-818 (2000).
26. Lohmann, D. R., Brandt, B., Hopping, W. Passarge, E. & Horstemke, B. The spectrum of RB1 germ-line mutations in hereditary retinoblastoma. Am. J. Hum. Genet. 58, 940-949 (1996).
27. Olson, J. M., Breslow, N. E. & Beckwith, J. B. Wilm's tumor and parental age: a report from the national Wilm's tumour study. Br. J. Cancer 67, 813-818 (1993).
28. Hassold, T. et al. Human aneuploidy: Incidence, origin, and etiology. Env. Mol. Mutagen. 28, 167-175 (1996).
29. Dryja, T. P., Morrow, J. F. & Rapaport, J. M. Quantification of the paternal allele bias for new germline mutations in the retinoblastoma gene. Hum. Genet. 100, 446-449 (1997).
30. Oldridge, M. et al. Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker in FGFR2. Hum. Mol. Genet. 6, 137-143 (1997).
31. Olshan, A. F. et al. Paternal age and the risk of congenital heart defects. Teratology 50, 80-84 (1994).
32. Zhang, Y. et al. Parental age at child's birth and son's risk of prostate cancer. Am. J. Epidemiol. 150, 1208-1212 (1999).
33. Tellier, A. L. et al. CHARGE syndrome: Report of 47 cases and review. Am. J. Med. Genet. 76, 402-409 (1998).
34. Fletcher, N. A. & Foley, J. Parental age, genetic mutation, and cerebral palsy. J. Med. Genet. 30, 44-46 (1993).
35. Bertram, L. et al. Paternal age is a risk factor for Alzheimer disease in the absence of a major gene. Neurogenetics 1, 277-280 (1998).
36. Antonarakis, J. P. et al. Factor VIII gene inversions in severe hemophilia: Results of an international consortium study. Blood 86, 2206-2212 (1995).
37. Cody, J. D. et al. Preferential toss of the paternal alleles in the 18q syndrome. Am. J. Med. Genet. 69, 280-286 (1997).
38. Dallapiccola, B. et al. Parental origin of chromosome-4p deletion in Wolf-Hirschhorn syndrome. Am. J. Med. Genet. 47, 921-924 (1993).
39. Overhauser, J. et al. Parental origin of chromosome-5 deletions in the Cri-du-chat syndrome. Am. J. Med. Genet. 37, 83-86 (1990).
40. Duyao, M. et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genet. 4, 387-392 (1993).
41. Kodaira, M., Satoh, C., Hiyama, K. & Toyama, K. Lack of effects of atomic bomb radiation on genetic instability of tandem-repetitive elements in human germ cells. Am. J. Hum Genet. 57, 1275-1283 (1995).
42. Ellegren, H. Heterogeneous mutation processes in human microsatellite DNA sequences. Nature Genet. 24, 400-402 (2000).
43. Xu, S., Peng, M., Fang, H. & Xu, X. The direction of microsatellite mutations is dependent upon alele length. Nature Genet. 24, 396-399 (2000).
44. Eyre-Walker, A. & Keightley, P. D. High genomic deleterious mutation rates in hominids. Nature 397, 344-347 (1999). The first estimate of the total deleterious mutation rate for all genes in humans.
45. Kimura, M. The Neutral Theory of Molecular Evolution (Cambridge Univ. Press, Cambridge, 1983).
46. Gianneli, F. et al. Mutation rates in humans. II. Sporadic mutation-specific rates and rate of detrimental human mutations inferred from hemophilia B. Am. J. Hum. Genet. 65, 1580-1587 (1999).
47. Cargil, M. et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genet. 22, 231-238 (1999).
48. Aparicio, S. A. J. R. How to count . . . human genes. Nature Genet. 25, 129-126 (2000).
49. Haldane, J. B. S. The effect of variation on fitness. Am. Nat. 71, 337-349 (1937). The original demonstration that mildly deleterious mutations cause the same reduction of fitness in the long run as drastic ones.
50. Muller, H. J. Our bad of mutations. Am. J. Hum. Genet. 2, 111-176 (1950).
51. Crow, J. F. The high spontaneous mutation rate: is it a health risk? Proc. Natl Acad. Sci. USA 94, 8380-8386 (1997).
52. Crow, J. F. Spontaneous mutation in man. Mutat. Res. 437, 5-9 (1999).
53. Akiyama, M. et al. Mutation frequency in human blood cells increases with age. Mutat. Res. 338, 141-149 (1995).
54. Bulmer, M. G. The Mathematical Theory of Quantitative Genetics (Clarendon, Oxford, 1985).
55. Crow, J. F. & Kimura, M. Efficiency of truncation selection. Proc. Natl Acad. Sci. USA 76, 396-399 (1979). A demonstration that quasi-truncation selection is almost as effective as strict truncation in eliminating deleterious mutant genes from the population.
56. Stern, C. Wilhelm Weinberg, 1862-1937. Genetics 47, 1-5 (1962).